Document is current
Any future updates will be listed below
-
Authors
Tang, Peng
Gao, Linrui
Zuo, Siyu
Zhang, Ke
Wang, Tierun
Zheng, Jian
Chen, Xi
Dong, Jie
Pang, Qingsong
Wang, Ping
Zhang, Wencheng
Zhang, Tian
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82272733)
National Natural Science Foundation of China (82102835)
National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine (QZ23-9)
Tianjin Key Medical Discipline Construction Project (TJYXZDXK-3-004B)
Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A)
- License Information
-
More Information
Article History
Received: 3 May 2025
Accepted: 9 March 2026
First Online: 13 March 2026
Declarations
:
: Institutional review board approval was obtained from the ethics committee of Tianjin Cancer Hospital (E20240610) in May 2024. This trial was published under NCT06452602 on ClinicalTrials.gov. All the participants signed an informed consent form.
: Not applicable.
: The authors declare no competing interests.
